AKEBIA THERAPEUTICS INC.
AKEBIA THERAPEUTICS INC.
2.79 USD (-1.06%)
15 min delayed data - NASDAQ Stocks
Open: 2.87
Change: -0.03
Volume: 6,178,096
Low: 2.72
High: 2.88
High / Low range: 0.16
Type: Stocks
Ticker: AKBA
ISIN:

Akebia Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

  • 7

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, will present at the 2019 Cantor Global Healthcare Conference at 8:55 a.m. ET on Thursday, October 3, 2019 in New York City.

A live audio webcast and replay of the presentation will be available on the Company’s website at www.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Business Wire
Business Wire, acquired by Berkshire Hathaway in 2006, is the global market leader in commercial news distribution. Thousands of member companies and organizations depend on Business Wire to transmit their full-text press releases, regulatory filings, photos and other multimedia content to journalists, financial professionals, investor services, regulatory authorities and consumers worldwide.